penn medicine
penn surgery
penn surgery home penn surgery clinical penn surgery education penn surgery research penn surgery administration

Michael A. Golden, M.D.
Vascular Surgery and Endovascular Therapy

 
  • Profile Home
  • Appointments
  • Education
  • Memberships
  • Research
  • Publications

Administrative/Clinical Offices:
Penn Presbyterian Medical Center
Department of Surgery
266 Wright Saunders Building
39th & Market Streets
Philadelphia, PA 19104
Administrative Assistant: Shannon Maratea
Administrative Telephone: 215-662-9660
Administrative Fax: 215-243-4649
Patient Appointments: 215-662-9660

Contact Information (internal use only)

michael.golden@uphs.upenn.edu

 

 

Dr. Golden is Chief of the Division of Vascular Surgery and Endovascular Therapy at Penn Presbyterian Medical Center, whose clinical interests include evaluation and treatment of patients with aortic, visceral, renal, carotid and peripheral arterial aneurysms and occlusive disease. He has an NIH-funded laboratory, and his research interests focus on the study of arterial and vein graft wall biology, in order to prevent vessel wall degeneration, vascular stenosis and bypass graft failure. Dr. Golden is exploring the role of growth factors and heat shock proteins in the vessel wall and their influence on current treatment modalities. He is also exploring methods of delivering genes to the vessel wall to control the failure of current treatment modalities.

 
Faculty Appointments
1981 - 1987 Clinical Fellow in Surgery
Harvard Medical School, Boston, Massachusetts
 
1989 - 1990 Clinical Fellow in Surgery
Harvard Medical School, Boston, Massachusetts
 
1990 - 1997 Assistant Professor of Surgery at HUP
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
1997 - present Associate Professor of Surgery at PPMC and HUP
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
 
Hospital and Administrative Appointments
1990 - present Attending Surgeon in Vascular Surgery
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
1990 - present Attending Surgeon in Vascular Surgery
Philadelphia Veterans Affairs Medical Center
Philadelphia, Pennsylvania
 
1995 - 2005 Director of Vascular Surgical Fellowship Training Program
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
1990 - 1997 Co-Director Vascular Noninvasive Laboratory
Philadelphia Veterans Affairs Medical Center
Philadelphia, Pennsylvania
 
1997 - present Director Vascular Noninvasive Laboratory
Philadelphia Veterans Affairs Medical Center
Philadelphia, Pennsylvania
 
1997 - 2003 Attending Surgeon in Vascular Surgery
Presbyterian University of Pennsylvania Medical Center
Philadelphia, Pennsylvania
 
2003 - present Associate Director, Vascular Noninvasive Laboratory
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
 
2003 - present Chief of Vascular Surgery
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
 
2006 - present Chief of Vascular Surgery
Philadelphia Veterans Affairs Medical Center
Philadelphia, Pennsylvania
 
Education/Training
1973 - 77 Undergraduate - B.A. - Amherst College (Economics/Chemistry)
 
1977 - 81 Graduate - M.D. - University of Pennsylvania School of Medicine
 
Postgraduate Training
1981 - 82 Intern in General Surgery
Brigham & Women's Hospital, Boston, Massachusetts
 
1982 - 86 Resident in General Surgery
Brigham & Women's Hospital, Boston, Massachusetts
 
1986 - 87 Chief Resident Surgeon
Brigham & Women's Hospital, Boston, Massachusetts
 
Fellowship Appointments
1987 - 89 Senior Research Fellow in Surgery
University of Washington, Seattle, Washington
 
1989 - 90 John Homans Fellow in Vascular Surgery
Brigham & Women's Hospital, Boston, Massachusetts
 
Memberships/Societies
 
National/International Societies
  • 1990 American Medical Association
  • 1990 American Society for Investigative Pathology
  • 1991 Association for Academic Surgery
    • Issues Committee, 1996-98; Chair, 1997-98
    • Nominating Committee, 1998-99
  • 1992 American Heart Association Basic Science Council
  • 1992 American Heart Association Circulation Council
  • 1993 American Association for Vascular Surgery
    (formerly ISCVS – North American Chapter)
  • 1993 American College of Surgeons-Fellow
  • 1993 International Society for Applied Cardiovascular Biology
  • 1993 International Society for Cardiovascular Surgery
  • 1993 International Society for Endovascular Specialists
  • 1995 Association of Program Directors in Vascular Surgery
    • Anatomy Committee – Chair, 1994-95
      AV Malformations and AV Fistulae Committee –
    • Chair, 1996-97
  • 1995 International Society for Surgery/Societe Internationale de Chirurgie
  • 1997 American Heart Association Cardiothoracic and Vascular Council
  • 1997 Society for Vascular Surgery
    • Lifeline Foundation Research and Education Committee,
      1998-present
    • Membership Committee, 2000-present
  • 1998 The Society of University Surgeons
  • 1999 Society for Clinical Vascular Surgery
Local/Regional Societies
  • 1986 Society of Brigham Surgical Alumni
  • 1989 Henry N. Harkins Surgical Society
  • 1990 Pennsylvania Medical Society
  • 1990 Philadelphia County Medical Society
  • 1990 Ravdin/Rhoads Surgical Society
  • 1992 Delaware Valley Vascular Society
    • Chair, Membership Committee, 1997-2001
    • Chair, Program Committee, 2001- present
  • 1993 The John Morgan Society
  • 1994 Eastern Vascular Society
    • Issues Committee, 1997-2001; Chair, 2000-2001
    • Program Committee, 2001-present
  • 2000 Philadelphia Academy of Surgery
 
Research
 

Our research focuses on understanding the regulation of the vascular smooth muscle response and the vessel wall remodeling response to injury. Atherosclerosis and the restenosis that complicates interventions for arterial disease are problematic and poorly understood. Vascular smooth muscle cell proliferation and migration appear integral to the observed pathology, as is the role of cell death. We are using several strategies to understand the regulation of vessel wall biology, to alter that biology and to control the vessel wall response to injury and remodeling in vivo.

Basic fibroblast growth factor has been shown to play a significant role in the arterial wall response to injury. We are using gene transfer techniques to manipulate the vessel wall cells at a molecular level in order to answer questions about the biology of the vessel wall and also to control the vessel wall response to injury. We use adenoviral mediated gene transfer, and we use cell and organ culture, and mouse, rat and rabbit models of arterial injury in addition to a rabbit model of vein graft adaptation to the arterial circulation. In addition to the animal work with histology and electron microscopy, we study smooth muscle proliferation, migration and apoptosis. We examine gene expression including growth factor expression at the protein level with western analysis and immunohistochemistry. We also study with northern analysis and polymerase chain reaction the expression of RNA. The effects of interruption of bFGF signaling with gene transfer have been dramatic. We have observed excellent responses to downregulation of bFGF signaling using adenoviral vectors encoding antisense bFGF and vectors encoding a dominant negative FGF receptor. We are continuing to dissect out the role of bFGF in vivo.

We are also using similar models, assays and methods to examine the role of hyperthermia and heat shock proteins in the vessel wall. We have found significant amelioration of the wall response to injury with induction of heat shock with hyperthermia and also with adenoviral-mediated heat shock protein 70i gene transfer.

Another regulator of smooth muscle growth and function is uteroglobin, also called clara cell protein. It is a multifunctional protein that has effects on platelets and smooth muscle and also acts as an inhibitor of inflammation. Overexpression of uteroglobin in the arterial wall confers protection against the effects of arterial injury, and we are currently using similar models and methods as described above to study this mechanism.

Research fellows have presented at national and regional meetings and won awards. Among others, the laboratory has received research funding from The American Heart Association, Foundations, the VA Merit Review and NHLBI-NIH RO1, and is currently funded through 2006.

 
Publications
 
Research Publications, Peer-Reviewed
  1. Wood, J.H. Simeone, F.A., Fink, E.A., Golden, M.A.: Hypervolemic hemodilution in experimental focal cerebral ischemia. J. Neurosurg. 59:500-509, 1983.
  2. Wood, J.H., Simeone, F.A., Fink, E.A., Golden, M.A.: Correlative aspects of hypervolemic hemodilution: Low molecular weight dextran infusions after experimental cerebral arterial occlusion. Neurology 34: 23-24, 1984.
  3. Golden, M.A., Au, Y.P.T., Kenagy, R.D., Clowes, A.W.: Growth factor gene expression by intimal cells in healing polytetrafluoroethylene grafts. J. Vasc. Surg. 11: 580-585, 1990.
  4. Golden, M.A., Hanson, S.R., Kirkman, T.R., Schneider, P.A., Clowes, A.W.: Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity. J. Vasc. Surg. 11: 838-845, 1990.
  5. Golden, M.A., Whittemore, A.D., Donaldson, M.C., Mannick, J.A.: Selective evaluation and management of coronary artery disease in patients undergoing repair of abdominal aortic aneurysms. Ann. Surg. 212:415-423, 1990.
  6. Golden, M.A., Au, Y.P.T., Kirkman, T.R., Wilcox, J.N., Raines, E.W., Ross, R., Clowes, A.W.: Platelet derived growth factor activity and mRNA expression in healing vascular grafts in baboons. The Association in vivo of PDGF mRNA and Protein with Cellular Proliferation. J. Clin. Invest. 87:406-414, 1991.
  7. Golden, M.A., Donaldson, M.C., Whittemore, A.D., Mannick J.A.: Evolving experience with thoracoabdominal aortic aneurysm repair at a single institution. J. Vasc. Surg. 13:792-7, 1991.
  8. Carpenter, J.P., Owen, R.S., Baum, R.A., Cope, C., Barker, C.F., Berkowitz, H.D., Golden, M.A., Perloff, L.J.: Magnetic resonance angiography of peripheral runoff vessels. J. Vasc. Surg. 16:807-815, 1992.
  9. Carpenter, J.P., Lieberman, M.D., Shlansky-Goldberg, R., Braverman, S.E., Soulen, M., Holland, G.A., Baum, R.A., Owen, R.S., Golden, M.A., Berkowitz, H.D., Barker, C.F., Perloff, L.J.: Infrageniculate bypass graft entrapment. J. Vasc. Surg. 18:81-89, 1993.
  10. Herrmann, H.C., Shunichiro, O., Hozakowska, E., LeVeen, R.F., Golden, M.A., Tomaszewski, J.E., Weisz, P.B., Barnathan, E.S.: Inhibition of smooth muscle cell proliferation and experimental angioplasty. Restenosis by ß-Cyclodextrin tetradecasulfate. Arteriosclerosis and Thrombosis. 13:924-931, 1993.
  11. Carpenter, J.P., Owen, R.S., Holland, G.A., Baum, R.A., Barker, C.F., Perloff, L.J., Golden, M.A., Cope, C.: Magnetic Resonance Angiography of the Aorta, Iliac, and Femoral Arteries. Surgery 16:17-23, 1994.
  12. Clair, D.G., Golden, M.A., Mannick, J.A., Whittemore, A.D., Donaldson, M.C. Randomized prospective study of angioscopically assisted in situ saphenous vein grafting. J. Vasc. Surg. 19:992-1000, 1994.
  13. Neubert,A.G., Golden,M.A., Rose,N.C.: Kasabach-Merritt coagulopathy complicating Klippel-Tenaunay-Weber syndrome in pregnancy. Obst. & Gync. 85(5 Pt 2):831-3, 1995.
  14. Bachinsky,W.B., Barnathan,E.S., Liu,H., Okada,S.S., Kuo,A., Raghunath,P.N., Muttreja,M., Caron,R.J.,Tomaszewski, J.E., Weisz, P.D., Golden, M.A.: Sustained inhibition of intimal thickening: In vitro and in vivo effects of polymeric beta-cyclodextrin sulfate. J. Clinic. Invest. 96:2583-2592, 1995.
  15. Holland,G.A., Dougherty,L., Carpenter,J.P., Golden,M.A., Gilfeather,M., Slossman,F., Schnall,M.D., Axel,L., Breathhold ultrafast 3-D gadolinium enhanced MR angiography of the aorta, and the renal and other visceral abdominal arteries. Am. J. Radiol. 166(4):971-81, 1996.
  16. Carpenter, J.P., Golden, M.A., Barker, C.F., Holland, G.A., Baum, R.A. The fate of bypass grafts to angiographically occult runoff vessels detected by magnetic resonance angiography. J Vasc. Surg. 23: 483-489, 1996.
  17. Toes, G.T., Barnathan, E.S., Liu, H., Raghunath, P.N., Tomaszewski, J.E., Caron, R.J., Weisz, P.B., van Oeveren, W., Golden, M.A., Inhibition of vein graft intimal and medial thickening by periadventitial application of a sulfated carbohydrate polymer. J. Vasc. Surg. 23:650-56, 1996.
  18. Golden, M.A., Modification of Vein Graft Adaptation Using Adenoviral Vectors. J. Vasc. Surg. 24:161-3, 1996.
  19. Golden, M.A., Intimal hyperplasia: Prospects for its control in the human. Vasc. Surg. 30(5):361-364, 1996.
  20. Carpenter, J.C., Holland, G.A., Golden, M.A., Barker, C.F., Lexa, F.J., Gilfeather, M., Schnall, M.D., Magnetic Resonance Angiography of the Aortic Arch. J. Vasc. Surg. 25:145-51, 1997.
  21. Siegelman, E.S., Gilfeather, M., Holland, G.A., Carpenter,J.P., Golden, M.A., Townsend, R.R., Schnall, M.D., Breath-hold ultrafast three dimensional gadolinium-enhanced magnetic resonance angiography of the renovascular system. Am. J. Radiol. 168:1035-1040, 1997.
  22. Ford, J.C., Shlansky-Goldberg, R.D., Golden, M.A., Magnetic Resonance Microscopy of the Vessel Wall in an Atherosclerotic Rabbit Model. J. Vasc. & Interven. Radiol. 8:93-99, 1997.
  23. Hanna, A.K., Fox, J., Neschis, S. Safford, D., Swain, J., Golden, M.A., Antisense Basic FGF Gene Transfer Reduces Neointimal Thickening After Arterial Injury. J. Vasc. Surg. 25: 320-325, 1997.
  24. Balcer, L.J., Galetta, S.L., Yousem, D, Golden, M.A., Asbury, A.K., Pupil-Involving Third Nerve Palsy and Carotid Stenosis: Rapid Recovery Following Endarterectomy. Ann. Neurol. 41:273-276,1997.
  25. Gilfeather,M., Holland, G.A., Siegelman, E.S., Schnall,M.D., Axel, L., Carpenter, J.P., Golden,M.A. Gadolinium enhanced ultra fast three dimensional spoiled gradient echo imagining of the abdominal aorta and visceral and iliac vessels: Technique and pictorial review. Radiographics 17: 423-432,1997.
  26. Golden, M.A., Vaughn, D.J., Crooks, G.W., Holland, G.A., Bavaria, J.E. Aortic dissection in a patient on chemotherapy for Hodgkin's disease. Angiology 48(12) 1063-1065, 1997.
  27. Neschis, D.D., Safford, S.D., Golden, M.A., Management of Pancreaticoduodenal Artery Aneurysms Presenting as Catastrophic Intraabdominal Bleeding. Surgery 123: 8-12, 1998.
  28. Neschis, D.G., Safford, S.D., Hanna, A.K., Fox, J.C., Golden, M.A., Antisense basic FGF gene transfer reduces early intimal thickening in a rabbit femoral artery balloon model. J. Vasc. Surg. 27:126-34,1998.
  29. Neschis, D.G., Safford, S.D., Raghunath, P.N., Langer, D.J., David, M.L., Hanna, A.K., Tomaszewski, J.E., Kariko, K., Barnathan, E.S., Golden, M.A. Thermal preconditioning prior to rat arterial balloon injury: Limitation of injury and sustained reduction of intimal thickening. Arterioscler. Thromb. Vasc. Biol. 18:120-26,1998.
  30. Okada, S.S.,Golden, M.A., Raghunath,P.N., Tomaszewski, J.E., David, M.L., Kuo, A., Kariko, K., Barnathan, E.S. Native atherosclerosis and vein graft arterialization: Association with increased urokinase receptor expression in vitro and in vivo. Thrombosis & Hemostasis 80(1): 140-7, 1998.
  31. Golden, M.A., and Neschis, D.G.: Gene Therapy. Seminars in Vascular Surgery 11(3);215-223, 1998.
  32. Velazquez, O.C., Carpenter, J.C., Baum,R.A., Barker,C.F., Golden, M.A., Criado,F., Pyron, A., Fairman, R.M. Perigraft air, fever, and leukocytosis after endovascular repair of abdominal aortic aneurysms. Am. J. Surg. 178: 185-89,1999.
  33. Levy, W.J., Carpenter, J.P., Fairman, R.M., Golden,M.A., Zager, E. The calibration and validation of a phase-modulated near infrared cerebral oximeter. J. Clin. Monitoring & Computing 15(2):103-108, 1999.
  34. Hanna, A.K., Durán, W.N., Leconte, I., Fox, J.C., Neschis, D.G., Hobson, R.W., Golden, M.A. Adenoviral-Mediated Expression of Antisense RNA to bFGF reduces tangential stress in arterialized vein grafts. J. Vasc. Surg. 31(4): 770-80, 2000.
  35. Larson,R.A., Naji,M., Lombardi, J.V., Naji, A., Koeberlein, B., Golden, M.A., Adenoviral mediated Uteroglobin gene transfer inhibits neointimal hyperplasia after balloon injury in the rat carotid artery. J. Vasc. Surg. 32 (6): 1111-7, 2000.
  36. Velazquez, O.C., Baum, R. A., Carpenter, J.P., Golden, M.A., Cohn, M., Pyeron, A., Barker, C.F. Relationship between preoperative patency of the inferior mesenteric artery and subsequent occurrence of type II endoleak in patients undergoing endovascular repair of abdominal aortic aneurysm. J. Vasc. Surg. 32(4): 777-88, 2000.
  37. Baum, R.A., Carpenter, J.P., Tuite, C.M., Velazquez, O.C., Soulen, M.C., Barker, C.F., Golden, M.A., Pyeron, A.M., Fairman, R.M. Diagnosis and treatment of inferior mesenteric arterial endoleaks after endovascular repair of abdominal aortic aneurysms. Radiology 215(2): 409-13, 2000.
  38. Carpenter, J.P., Neschis, D.G., Fairman, R. M., Barker, C.F., Golden, M.A., Velazquez, O.C., Mitchell, M.E. Failure of abdominal aortic aneurysm graft limbs. J. Vasc. Surg. 33:296-303, 2001.
  39. Shammash, J.B., Trost, J.C., Gold, J.M., Berlin, J.A., Golden, M.A., Kimmel, M.D. Perioperative B-blocker withdrawal and mortality in vascular surgical patients. American Heart J. 141:148-53, 2001.
  40. Baum, R. A. Carpenter, J.P., Cope, C., Golden, M.A., Velazquez, O.C., Neschis, D.G., Mitchell, M.E., Barker, C.F. Aneurysm sac pressure measurements after endovascular repair of abdominal aortic aneurysms. J. Vasc. Surg. 33(1): 32-41, 2001.
  41. Velazquez OC, Larson RA, Milner R, Baum RA, Carpenter JP, Golden MA, Mitchell ME, Barker CF, Pyeron A, Fairman RM. Gender-related differences in infrarenal aortic aneurysm morphologic features: Issues relevant to Ancure and Talent endografts. J. Vasc. Surg. 33:S77-84, 2001.
  42. Neschis DG, Velazquez OC, Baum RA, Carpenter JP, Golden MA, Mitchell ME, Barker CF, Pyeron A, Fairman RM. The role of magnetic resonance angiography for endovascular endoprosthetic design. J. Vasc. Surg. 33:488-94, 2001.
  43. Fairman RM, Velazquez OC, Criado FJ, Carpenter JP, Baum RA, Golden MA, Pyeron AM, Barker CF. Endovascular repair of aortic aneurysms: Critical events and adjunct procedures. J. Vasc. Surg. 33(6):1226-32, 2001.
  44. Carpenter JP, Baum RA, Barker CF, Golden MA, Velazquez OC, Mitchell ME, Fairman RM. Endovascular AAA repair in patients with renal insufficiency: strategies for reducing adverse renal events. Cardiovasc. Surg. 9(6):559-64, 2001.
  45. Lombardi, J.V., Naji, M., Larson, R.A., Ryan, S.V., Naji, A., Koeberlein, B., Golden, M.A.. Adenoviral mediated Uteroglobin gene transfer to the adventitia reduces arterial intimal hyperplasia. J. Surg. Res. 99(2):377-80, 2001.
  46. Carpenter JP, Baum RA, Barker CF, Golden MA, Mitchell ME, Velazquez OC, Fairman RM. Impact of exclusion criteria on patient selection for endovascular abdominal aortic aneurysm repair. J Vasc Surg 34(6):1050-4, 2001.
  47. Baum RA, Carpenter JP, Golden MA, Velazquez OC, Clark, TW, Stavropoulous SW, Cope C, Fairman RM. Treatment of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms: comparison of transarterial and translumbar techniques. J Vasc Surg. 35(1):23-9, 2002.
  48. Carpenter JP, Baum RA, Barker CF, Golden MA, Velazquez OC, Mitchell ME, Fairman RM. Durability of benefits of endovascular versus conventional abdominal aortic aneurysm repair. J Vasc Surg. 35(2):222-8, 2002.
  49. Murciano JC, Harshaw D, Neschis DG, Koniaris L, Bdeir K, Medinilla S, Fisher AB, Golden MA, Cines DB, Nakada MT, Muzykantov VR. Platelets inhibit the lysis of pulmonary microemboli. Am J Physiol Lung Cell Mol Physiol. 282(3):529-39, 2002.
  50. Fairman RM, Carpenter JP, Baum RA, Larson RA, Golden MA, Barker CF, Mitchell ME, Velazquez OC. Potential impact of therapeutic warfarin treatment on type II endoleaks and sac shrinkage rates on midterm follow-up examination. J Vasc Surg. 35(4):679-85, 2002.
  51. Hunt, J.L., Fairman, R., Mitchell, M., Carpenter, J.P., Golden, M.A., Khalapyan, T., Wolfe, M., Neschis, D., Milner, R., Scoll, B., Cusack, A, Mohler, E.R. Bone formation in carotid plaques: A clinicopathological study. Stroke.33: 1214-1219, 2002.
  52. Goldman, R.J., Brewley, B.I., Golden, MA. Electrotherapy reoxygenates inframalleolar ischemic wounds on diabetic patients: a case series. Adv. Skin Wound Care, 15(3):112-20, 2002.
  53. Meneveau, N.F., Klugherz, B. D., Chaqour, B., Anand, V., Tomaszewski, J.E., Joullie, M.M., Macarak, E., Golden, M.A., Weisz, P. B., Wilensky, R. L., B-Cyclodextrin tetradecasulfate, a novel cyclic oligosaccharide, inhibits thrombus and neointimal formation after coronary vascular injury. CoronaryArtery Disease, 13, ( 3): 2002.
  54. Goldman RJ, Brewley BI, Golden MA. Electrotherapy reverses inframalleolar ischemia: a retrospective, observational study. Adv Skin Wound Care, 16(2):79-89:2003.
  55. Meneveau NF, Klugherz BD, Chaquor B, Golden MA, Jouille MM, Macarek E, Weisz PB, Wilensky RL. Separate and Combined Effects of Local and Continuous Intravenous Administration of beta-Cyclodextrin Tetradecasulfate on Intimal Hyperplasia after Angioplasty in Porcine Coronary Arteries.J Cardiovasc Pharmacol Ther. 8(1):53-60:2003.
  56. Milner R, Golden MA, Velazquez OC, Fairman RM. A new endovascular approach to treatment of acute iliac limb occlusions of bifurcated aortic stent grafts with an exoskeleton. J Vasc Surg, 37(6):1329-31, 2003.
  57. Stavropoulos SW, Carpenter JP, Fairman RM, Golden MA, Baum RA. Inferior vena cava traversal for translumbar endoleak embolization after endovascular abdominal aortic aneurysm repair. J Vasc Interv Radiol. Sep;14(9):1191-4, 2003.
  58. Pitsilos S, HuntJ, Mohler ER, Prabhakar AM, Poncz M, Dawicki J, Khalapyan TZ, Wolfe ML, Fairman R, Mitchell M, Carpenter J, Golden MA, Cines DB, Sachias BS. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Hemost. 90(6):971-2, 2003.
  59. Lombardi JV, Fairman RM, Golden MA, Carpenter JP, Mitchell M, Barker C, McBride A, Velazquez OC. The utility of commercially available endografts in the treatment of contained ruptured abdominal aortic aneurysm with hemodynamic stability. J Vasc Surg 40(1):154-60, 2004.
  60. Velazquez OC, Woo EY, Carpenter JP, Golden MA, Barker C, Fairman RM. Decreased use of iliac extensions and reduced graft junctions with software-assisted centerline measurements in selection of endograft components for endovascular aneurysm repair. J Vasc Surg 40(2):222-7, 2004.
  61. Goldman R, Rosen M, Brewley B, Golden M. Electrotherapy promotes healing and microcirculation of infrapopliteal ischemic wounds: a prospective pilot study. Adv Skin Wound Care 17(6):284-94, 2004.
  62. Fairman RM, Velazquez OC, Carpenter JC, Woo E, Baum RA, Golden MA, Kritpracha B, Criado F. Midterm pivotal trial results of the Talent Low Profile System for repair of abdominal aortic aneurysm: analysis of complicated versus uncomplicated aortic necks. J Vasc. Surg. 40(6):1074-82, 2004.
  63. Wolf RL, Wehrli SL, Popescu AM, Woo JH, Song HK, Wright AC, Mohler, EM, Harding JD, Zager EL, Fairman RM, Golden MA, Velazquez OC, Carpenter JC, Wehrli FW. Mineral Volume and Morphology in Carotid Plaque Specimens Using High-Resolution MRI and CT. Arterioscler. Thromb. Vasc. Biol. 25:1729-1735, 2005.
  64. Karmacharya J, Parmer SS, Antezana JN, Fairman RM, oo EY, Velazquez OC, Golden MA, Carpenter JC. Outcomes of Accessory Renal Artery Occlusion During Endovascular Aneurysm Repair. . J Vasc. Surg. 43(1):8-13, 2006.
  65. Woo EY, Fairman RM, Velazquez OC, Golden MA, Karmacharya J, Carpenter JP. Endovascular Therapy of Symptomatic Innominate-Subclavian Arterial Occlusive Lesions. Vasc. Endovasc. Surg. 40(1):27-33, 2006.
  66. Jones CE, Wolf RL, Detre JA, Das B, Saha PK, Wang J. Zhang Y, Song HK, Wright AC, Mohler EM, Fairman RM, Zager EL, Velazquez OC, Golden MA, Carpenter JP, Wehrli FW. Structural MRI of carotid artery atherosclerotic lesion burden and characterization of hemispheric cerebral blood flow before and after carotid endarterectomy. NMR Biomed. 19(2): 198-208, 2006.
  67. Moise MA, Woo EY, Velazquez OC, Fairman RM, Golden MA, Mitchell ME, Carpenter JP. Barriers to endovascular aortic aneurysm repair: past experience and implications for future device development. Vasc. Endovasc. Surg. 40(3):197-203, 2006.
Research Publications, Non-Peer-Reviewed
  1. Schiebler M.L., Listerud J., Baum R.A., Carpenter J.P., Weigle J., Holland G., Schnall M., Cope, C., Pentecost, M., Gupta, K., Golden, M.A., Barker, C., Kressel, H., Axel, L., MR arteriography of the pelvis and lower extremities. In Magnetic Resonance Quarterly. 9(3):152-187, 1993.
  2. Golden,M.A., Kariko,K., David,M.L., Okada,S.S., Hanna,A.K., Barnathan, E.S., Increased urokinase receptor expression in proliferating vascular smooth muscle cells and in arterialized vein grafts in rabbits. Surg. For. XLVI: 384-386, 1995.
  3. Safford, S., Zhang, Z., Neshcis, D., Kuo, A., Raghunath, P., Hanna, A., Weisz, P., Joullie, M., Barnathan, E., Golden, M.A. Local delivery of a novel Octyl-B-Cyclodextrin polysulfate reduces intimal thickening after vascular injury in rats. Surg. For. XLVIII:413-414, 1997.
  4. Neschis, D., Safford, S., Hanna, A., Leconte, I., Swain, J., Fox, J., Golden, M.A. Kinase deleted dominant negative FGF receptor gene transfer inhibits intimal hyperplasia after injury in the rat carotid artery. Surg. For. XLVIII: 437-439, 1997.
  5. Ryan, SV, Naji, M, Koeberlein, AS, Larson, RA, Golden, MA. Expression of Heat Shock Protein -70i inhibits neointimal hyperplasia in the injured rat carotid after adenoviral gene transfer of heat shock protein-70i. Surg. For. LII: 358-360, 2001.
  6. Golden, M.A., and Hanna, A.K., Modification of Vein Graft Adaptation Using Adenoviral Vectors, in New Advances in Vascular Biology and Molecular and Cardiovascular Medicine, (1998).
  7. Larson, R. A., and and Golden, M.A., The Biology of Restenosis and Intimal Hyperplasia, in Vascular Surgery: Principles and Practice, third edition, R. W. Hobson, II (editor) St. Louis, MO, 2004, pp. 325-340.
Editorial, Reviews, Chapters
  1. Golden, M.A., Clowes, A.W.,: Prospects for successful drug prophylaxis of neointimal hyperplasia. In: Veith, F.J. (Ed) Current Critical Problems in Vascular Surgery. Vol 2 St. Louis Quality Medical Publishing Inc., 1990
  2. Golden, M.A., Downing, S.W.: Peripheral vascular complications of stent placement. In: Herrmann, H.C., Hirshfeld J.W. (Ed) Clinical Use of the Palmaz-Schatz Balloon Expandable Intracoronary Stent. New York, Futura Publishing Company, Inc., 1993, pp. 137-150.
  3. Golden, M.A. [Book Review] Cell Biology of Extracellular Matrix by Elizabeth D. Hay. J Vasc Surg 1993(18) p142.
  4. Carpenter, J.P., Owens, R.S., Baum, R.A., Cope, C., Barker,C.F., Berkowitz, H.D., Golden, M.A., Perloff, L.J., Magnetic Resonance Angiography of Peripheral Runoff Vessels [letter] J. Vasc. Surg 1993 17(6):1136-7.
  5. Golden, M.A. [Invited Commentary] "Assessment and Quantification of Regional Arterial Perfusion Reserve in Patients with Peripheral Occlusive and Small-Vessel Disease by Rubidium 82-Positron Emission Tomography," J Vasc Surg 1996 30 (4):331-336.
  6. Golden, M.A. [Book Review] Vascular Surgery, (4th Ed.) Robert B. Rutherford, M.D.(ed) J Amer Coll Surg 1996 183(6):654.
  7. Neschis, D.N., Mohler, E.R., Golden, M.A., Indications for surgery in the patient with claudication, in Vascular Medicine in: UpToDate in Medicine, ed. Rose, B.D., Vol 5(1) Boston, UpToDate, Inc. 1997.
  8. Golden, M.A. [Invited Commentary] "Electron Microscopic Luminal Surface Characteristics of Carotid Plaques." Vasc. Surg. 31(6) Nov/Dec 1997, p. 774.
  9. Neschis, D.G., Golden, M.A.. Clinical Manifestations and Evaluation of Limb Threatening Ischemia, in Vascular Medicine in: UpToDate in Medicine, ed. Rose, B.D., Vol 5(1) Boston, UpToDate, Inc. 1997.
  10. Neschis, D.G., Golden, M.A.: Treatment of Limb Threatening Ischemia, Vascular Medicine in: UpToDate in Medicine, ed. Rose, B.D., Vol 5(1) Boston, UpToDate, Inc. 1997.
  11. Neschis, D.G., and Golden, M.A., Arterial Disease of the Lower Extremity, in Norton, Bollinger, Chang,Lowry, Mulvihill, Pass, Thompson, (eds) Surgery: Scientific Basis and Clinical Evidence, Springer, New York, NY, 2000, pp. 1067-1082.
  12. Neschis, D.G., and Golden, M.A., Vascular Disease and Vascular Surgery.(Chapter 21) In: Kreisel, Krupnick, Kaiser, (Eds). The Surgical Review: An integrated Basic and Clinical Science Study Guide, Lippincott-Williams & Wilkins, 2001, pp. 333-354.
  13. Golden, M.A. Contributor, Yearbook of Vascular Surgery 2002, J.M. Porter, (Editor), Mosby, St. Louis, MO, 2002.
  14. Golden, M.A., and Hanna, A.K., Modification of Vein Graft Adaptation Using Adenoviral Vectors, in New Advances in Vascular Biology and Molecular and Cardiovascular Medicine, (1998).
  15. Larson, R. A., and Golden, M.A., The Biology of Restenosis and Intimal Hyperplasia, in Vascular Surgery: Principles and Practice, third edition, R. W. Hobson, II (editor) St. Louis, MO, 2004, pp.325-340.

Dr. Michael Golden

 
footer Terms of Use Legal Disclaimer Site Map Contact Us Financial Assistance About Penn Medicine Privacy Statement
penn medicine